Lipid Metabolism Practice Questions

Q: Which of the following organs cannot utilize fatty acids for energy, except?

Brain. **Explanation:** The correct answer is **C. Brain**. The primary reason the brain cannot utilize long-chain fatty acids for energy is the **Blood-Brain Barrier (BBB)**. Fatty acids circulate in the blood bound to albumin; this bulky complex cannot cross the BBB. Furthermore, the brain lacks significant levels of the enzymes required for **beta-oxidation**, and relying on fatty acid oxidation would be metabolically risky as it consumes high amounts of oxygen and can generate harmful reactive oxygen species (ROS). During starvation, the brain adapts by using **ketone bodies** (acetoacetate and beta-hydroxybutyrate), which are water-soluble and can cross the BBB, but it never utilizes fatty acids directly. **Analysis of Incorrect Options:** * **A. Liver:** The liver is the central hub for fatty acid metabolism. It actively performs beta-oxidation to provide energy for gluconeogenesis. * **B. Muscle:** Both skeletal and cardiac muscles are major consumers of fatty acids, especially during resting states or prolonged low-intensity exercise. * **D. Kidney:** The renal cortex utilizes fatty acids as its preferred fuel source to meet the high energy demands of tubular reabsorption. **High-Yield NEET-PG Pearls:** * **RBCs** also cannot utilize fatty acids because they lack **mitochondria** (the site of beta-oxidation). * The brain's absolute requirements are **Glucose** (normal state) and **Ketone Bodies** (starvation). * **Essential Fatty Acids:** Linoleic and Linolenic acid must be provided in the diet as humans lack enzymes to introduce double bonds beyond carbon 9.

Q: Salt losing hydroxylase deficiency is characterized by?

Hyponatremia. **Explanation:** Salt-losing hydroxylase deficiency most commonly refers to **21-hydroxylase deficiency**, the most frequent cause of **Congenital Adrenal Hyperplasia (CAH)**. **1. Why Hyponatremia is the Correct Answer:** In this condition, a deficiency of the enzyme 21-hydroxylase leads to a failure in the synthesis of **Aldosterone** and **Cortisol**. Aldosterone is responsible for sodium reabsorption and potassium excretion in the distal renal tubules. Its absence results in "salt wasting"—the excessive loss of sodium in the urine—leading to profound **Hyponatremia**. This is the hallmark biochemical finding in the salt-wasting form of CAH. **2. Analysis of Other Options:** * **Hyperkalemia (Option B):** While hyperkalemia *is* a classic feature of salt-losing CAH (due to lack of aldosterone-mediated potassium excretion), the question asks for the primary characterization of "salt losing." In medical entrance exams, when both are present, hyponatremia is often prioritized as the defining "salt-losing" event, though both are clinically significant. * **Hypoglycemia (Option C):** Deficiency of Cortisol (a counter-regulatory hormone) can lead to hypoglycemia, especially during stress. However, it is a secondary metabolic consequence rather than the defining feature of the "salt-losing" state. * **Hypocalcemia (Option D):** Calcium metabolism is generally unaffected in CAH; this is not a feature of hydroxylase deficiencies. **High-Yield Clinical Pearls for NEET-PG:** * **Most Common Enzyme:** 21-hydroxylase deficiency (>90% of cases). * **Biochemical Marker:** Elevated **17-hydroxyprogesterone (17-OHP)**. * **Clinical Presentation:** Ambiguous genitalia in females (virilization) and salt-wasting crisis (vomiting, dehydration, shock) in the second week of life. * **11-beta-hydroxylase deficiency:** Characterized by **hypertension** (due to 11-deoxycorticosterone buildup) rather than salt-wasting.

Q: In children, what is the most commonly recognized form of Familial Hyperlipidemia?

Combined hyperlipidemia. **Explanation:** **Familial Combined Hyperlipidemia (FCHL)** is the most common genetic dyslipidemia, affecting approximately 1 in 100 to 1 in 200 individuals. In the pediatric population, it is the most frequently recognized form of familial hyperlipidemia. **Why Combined Hyperlipidemia is correct:** FCHL is characterized by an overproduction of **Apolipoprotein B-100**, leading to increased VLDL secretion and subsequent elevation of LDL. Clinically, it presents with variable patterns: elevated cholesterol, elevated triglycerides, or both. Because it is highly prevalent in the general population and often manifests early due to genetic predisposition and lifestyle factors, it remains the most common diagnosis in children presenting with lipid abnormalities. **Why other options are incorrect:** * **Hypertriglyceridemia (Type IV):** While common in adults (often secondary to obesity or diabetes), it is less frequently diagnosed as a primary genetic disorder in children compared to FCHL. * **Hypercholesterolemia (Type IIa):** Specifically referring to Familial Hypercholesterolemia (LDL receptor defect). While significant, its prevalence (1 in 250-500) is lower than the combined variations seen in FCHL. * **Hyperchylomicronemia (Type I):** This is a rare autosomal recessive disorder (deficiency of LPL or Apo C-II). Though it presents in infancy with eruptive xanthomas and pancreatitis, it is statistically the least common. **High-Yield Clinical Pearls for NEET-PG:** * **FCHL (Type IIb):** Characterized by ↑LDL, ↑VLDL, and ↑Apo B-100. Unlike Familial Hypercholesterolemia, **tendon xanthomas are usually absent** in FCHL. * **Diagnosis:** Suspect in children with a family history of premature Coronary Artery Disease (CAD) before age 55. * **Type I vs. Type IV:** Type I presents with milky plasma and pancreatitis; Type IV is associated with insulin resistance.

Q: Trans fatty acids are known to form during which process?

Hydrogenation of oils. **Explanation:** **1. Why Option A is Correct:** Trans fatty acids (TFAs) are primarily formed during the **partial hydrogenation of vegetable oils**. In this industrial process, hydrogen is added to unsaturated liquid oils (like soybean or sunflower oil) in the presence of a catalyst (e.g., Nickel) to make them solid at room temperature and increase their shelf life. While the goal is to saturate the double bonds, some cis-double bonds are unintentionally isomerized into the **trans configuration**, resulting in trans fats. **2. Why Other Options are Incorrect:** * **B. Beta-oxidation of palmitate:** This is the catabolic pathway where fatty acids are broken down into Acetyl-CoA units to generate energy. It does not involve the isomerization of double bonds into the trans form. * **C. Rancidity of fats:** This refers to the oxidation (oxidative rancidity) or hydrolysis (hydrolytic rancidity) of fats leading to unpleasant odors. While it damages fats, its primary products are aldehydes, ketones, and free fatty acids, not trans-isomerization. * **D. Prostaglandin biosynthesis:** Prostaglandins are synthesized from arachidonic acid (a polyunsaturated fatty acid) via the cyclooxygenase (COX) pathway. These molecules maintain specific cis-configurations or cyclic structures. **3. High-Yield Clinical Pearls for NEET-PG:** * **Health Impact:** Trans fats are highly atherogenic. They **increase LDL** (bad cholesterol) and **decrease HDL** (good cholesterol), significantly raising the risk of Coronary Artery Disease (CAD). * **Natural Sources:** While most trans fats are industrial, small amounts occur naturally in the milk and meat of ruminants (e.g., vaccenic acid) due to bacterial fermentation in the rumen. * **Biochemical Structure:** In trans fatty acids, the hydrogen atoms are on opposite sides of the double bond, making the chain linear and similar to saturated fats in physical properties.

Q: Which lipid abnormality is commonly associated with Diabetes Mellitus?

Triglycerides. **Explanation:** The characteristic lipid profile in patients with Diabetes Mellitus (specifically Type 2) is known as **Diabetic Dyslipidemia**. The hallmark of this condition is **Hypertriglyceridemia**. **1. Why Triglycerides are the correct answer:** In the insulin-deficient or insulin-resistant state of Diabetes, there is increased lipolysis in adipose tissue [1], leading to an influx of free fatty acids (FFAs) into the liver. The liver uses these FFAs to synthesize **Very Low-Density Lipoprotein (VLDL)**. Since VLDL is rich in triglycerides [3], its overproduction—coupled with decreased clearance due to reduced activity of the insulin-dependent enzyme **Lipoprotein Lipase (LPL)**—results in significantly elevated serum triglyceride levels. **2. Why other options are incorrect:** * **High-density lipoprotein (HDL):** In Diabetes, HDL levels are typically **low**, not high. This is due to the exchange of triglycerides from VLDL for cholesterol in HDL, making the HDL particles small, dense, and easily cleared by the kidneys [2]. * **Low-density lipoprotein (LDL):** While LDL levels may not always be significantly higher in quantity compared to non-diabetics, the **quality** changes. Diabetics have a preponderance of **Small Dense LDL (Pattern B)**, which is highly atherogenic [2]. * **Cholesterol:** Total cholesterol may be elevated, but it is a non-specific marker. Hypertriglyceridemia is the more specific and primary driver of the diabetic lipid triad. **High-Yield Clinical Pearls for NEET-PG:** * **The Diabetic Lipid Triad:** 1. High Triglycerides, 2. Low HDL, 3. Small Dense LDL particles. * **Target of Therapy:** While Triglycerides are the primary abnormality, **LDL-C** remains the primary target of statin therapy to reduce cardiovascular risk. * **Key Enzyme:** Insulin deficiency leads to decreased **Lipoprotein Lipase** activity, the most common cause of hypertriglyceridemia in DM.

Q: Which of the following statements is WRONG about X-linked adrenoleukodystrophy?

It is a mitochondrial disorder.. **Explanation:** **1. Why Option A is the Correct (Wrong) Statement:** X-linked Adrenoleukodystrophy (X-ALD) is a **peroxisomal disorder**, not a mitochondrial one. It is caused by a mutation in the **ABCD1 gene**, which encodes a peroxisomal membrane transporter protein. This protein is essential for the entry of Very Long Chain Fatty Acids (VLCFAs) into the peroxisome for degradation via **beta-oxidation**. **2. Analysis of Other Options:** * **Option B (Addison’s disease):** X-ALD frequently involves the adrenal cortex. The accumulation of VLCFAs is toxic to adrenal cells, leading to primary adrenal insufficiency. In many pediatric cases, Addison’s disease may be the first clinical manifestation before neurological symptoms appear. * **Option C (Accumulation of VLCFAs):** This is the biochemical hallmark of the disease. Due to the defective ABCD1 transporter, VLCFAs (fatty acids with >22 carbons) cannot be oxidized and thus accumulate in the blood and tissues (especially the brain and adrenal glands). * **Option D (Progressive neuronal demyelination):** The accumulation of VLCFAs in the CNS triggers an inflammatory response that destroys the myelin sheath. This leads to progressive cognitive decline, vision/hearing loss, and motor impairment. **High-Yield Clinical Pearls for NEET-PG:** * **Inheritance:** X-linked recessive (primarily affects males). * **Diagnosis:** Elevated plasma levels of **VLCFAs** (specifically C26:0). * **Zellweger Syndrome:** Contrast X-ALD with Zellweger Syndrome, which is a generalized defect in peroxisomal biogenesis (affecting all peroxisomal functions), whereas X-ALD is a specific transporter defect. * **Lorenzo’s Oil:** A dietary mixture of glyceryl trioleate and glyceryl trierucate used to lower VLCFA levels in some patients.

Q: Which of the following apoproteins activate the esterification of cholesterol?

Apo A1. ### Explanation The correct answer is **Apo A1**. **1. Why Apo A1 is correct:** Apo A1 is the primary structural protein of **High-Density Lipoprotein (HDL)**. Its most critical functional role is the activation of the enzyme **Lecithin-Cholesterol Acyltransferase (LCAT)**. LCAT catalyzes the esterification of free cholesterol (on the surface of HDL) into cholesterol esters (which move into the core). This process is essential for **Reverse Cholesterol Transport**, allowing HDL to mature from a discoid shape to a spherical shape and effectively carry cholesterol from peripheral tissues back to the liver. **2. Why the other options are incorrect:** * **Apo E:** Primarily serves as a ligand for the **LDL receptor** and the **LRP (LDL Receptor-related Protein)**. It is crucial for the hepatic uptake of chylomicron remnants and IDL. * **Apo C:** This family has diverse roles; most notably, **Apo C-II** is the essential activator of **Lipoprotein Lipase (LPL)**, which hydrolyzes triglycerides in chylomicrons and VLDL. **Apo C-III** inhibits LPL. * **Apo B100:** The structural protein for VLDL, IDL, and LDL. It acts as the primary ligand for the **LDL receptor**, facilitating the endocytosis of LDL into peripheral tissues and the liver. **3. High-Yield Clinical Pearls for NEET-PG:** * **LCAT vs. ACAT:** LCAT (activated by Apo A1) works in the **plasma** (extracellularly), while ACAT (Acyl-CoA:cholesterol acyltransferase) works **intracellularly** to store cholesterol. * **Tangier Disease:** A deficiency in the ABCA1 transporter leads to a near-absence of HDL and Apo A1, characterized by orange tonsils and hepatosplenomegaly. * **Fish-Eye Disease:** A partial deficiency of LCAT leading to corneal opacities.

Q: What is the chemical process involved in the conversion of progesterone to glucocorticoids?

Hydroxylation. **Explanation:** The conversion of progesterone to glucocorticoids (such as cortisol) is a fundamental pathway in steroidogenesis occurring in the adrenal cortex. This process is driven by a series of **Hydroxylation** reactions. **1. Why Hydroxylation is Correct:** Steroid hormones are derived from cholesterol (a 27-carbon molecule). Progesterone (a 21-carbon molecule) serves as a precursor for cortisol. To convert progesterone into cortisol, specific hydroxyl groups (-OH) must be added at specific carbon positions. This is mediated by **Cytochrome P450 enzymes**: * **21-hydroxylase:** Converts progesterone to 11-deoxycorticosterone. * **17α-hydroxylase:** Converts progesterone to 17-hydroxyprogesterone. * **11β-hydroxylase:** Final step in cortisol synthesis. Since the primary chemical change is the addition of -OH groups, the process is hydroxylation. **2. Why Other Options are Incorrect:** * **Methylation:** Involves adding a methyl group (-CH3). This is common in DNA regulation or catecholamine metabolism (e.g., PNMT enzyme), but not in the conversion of progesterone to glucocorticoids. * **Carboxylation:** Involves adding a carboxyl group (-COOH), typically requiring Biotin (Vitamin B7). Examples include pyruvate carboxylase or acetyl-CoA carboxylase. **Clinical Pearls for NEET-PG:** * **Congenital Adrenal Hyperplasia (CAH):** Most commonly caused by a deficiency in **21-hydroxylase** (90% of cases), leading to decreased cortisol and increased androgens. * **Rate-limiting step of steroidogenesis:** The conversion of cholesterol to pregnenolone by the enzyme **Desmolase** (Cholesterol side-chain cleavage enzyme). * **Localization:** Hydroxylation reactions in steroid synthesis occur in both the **Mitochondria** and the **Smooth Endoplasmic Reticulum**.

Q: Farber's disease is caused by a deficiency in which enzyme?

Ceramidase. **Explanation:** **Farber’s disease** (also known as Farber’s lipogranulomatosis) is a rare autosomal recessive lysosomal storage disorder. It is caused by a deficiency of the enzyme **acid ceramidase**. 1. **Why Ceramidase is correct:** Acid ceramidase is responsible for breaking down **ceramide** into sphingosine and a free fatty acid within the lysosomes. When this enzyme is deficient, ceramide accumulates in various tissues, particularly in the joints, skin, and central nervous system. This leads to the classic clinical triad: **painful swollen joints, subcutaneous nodules, and a hoarse cry** (due to laryngeal involvement). 2. **Why other options are incorrect:** * **Alpha-galactosidase:** Deficiency of Alpha-galactosidase A causes **Fabry disease**, characterized by angiokeratomas, peripheral neuropathy, and renal failure. * **Debranching enzyme:** Deficiency of this enzyme (Amylo-1,6-glucosidase) causes **Cori disease (GSD Type III)**, a glycogen storage disorder presenting with hepatomegaly and hypoglycemia. **High-Yield Clinical Pearls for NEET-PG:** * **Mnemonic:** "Farber’s is **C**eramide **A**ccumulation" (Farber = **C**eramidase). * **Pathognomonic finding:** Biopsy of nodules shows "Farber bodies" (comma-shaped structures or curvilinear bodies) within macrophages. * **Key Triad:** Arthritis (joint deformity), Subcutaneous nodules, and Hoarseness of voice. * Farber’s disease is unique among sphingolipidoses for its prominent involvement of the joints and larynx.

Question 1

Which of the following organs cannot utilize fatty acids for energy, except?

Accepted Answer

Brain

Answer

Liver

Answer

Muscle

Answer

Kidney

Question 2

Salt losing hydroxylase deficiency is characterized by?

Accepted Answer

Hyponatremia

Answer

Hyperkalemia

Answer

Hypoglycemia

Answer

Hypocalcemia

Question 3

In children, what is the most commonly recognized form of Familial Hyperlipidemia?

Accepted Answer

Combined hyperlipidemia

Answer

Hypertriglyceridemia

Answer

Hypercholesterolemia

Answer

Hyperchylomicronemia

Question 4

Trans fatty acids are known to form during which process?

Accepted Answer

Hydrogenation of oils

Answer

Beta oxidation of palmitate

Answer

Rancidity of fats

Answer

Prostaglandin biosynthesis

Question 5

Which lipid abnormality is commonly associated with Diabetes Mellitus?

Accepted Answer

Triglycerides

Answer

High-density lipoprotein (HDL)

Answer

Low-density lipoprotein (LDL)

Answer

Cholesterol

Question 6

Which of the following statements is WRONG about X-linked adrenoleukodystrophy?

Accepted Answer

It is a mitochondrial disorder.

Answer

It may present as Addison's disease.

Answer

It involves the accumulation of very long chain fatty acids.

Answer

It involves progressive neuronal demyelination.

Question 7

Which of the following apoproteins activate the esterification of cholesterol?

Accepted Answer

Apo A1

Answer

Apo E

Answer

Apo C

Answer

Apo B100

Question 8

What is the chemical process involved in the conversion of progesterone to glucocorticoids?

Accepted Answer

Hydroxylation

Answer

Methylation

Answer

Carboxylation

Answer

None of the above

Question 9

Which of the following best describes the properties of acetyl-CoA carboxylase?

Accepted Answer

Required Cofactor - Biotin; Intracellular Location - Cytoplasmic; Allosteric Modifier - Citrate; Enzyme That Catalyzes a Covalent Modification - AMP-activated protein kinase

Answer

Required Cofactor - Biotin; Intracellular Location - Mitochondrial; Allosteric Modifier - Citrate; Enzyme That Catalyzes a Covalent Modification - PKA

Answer

Required Cofactor - Thiamin; Intracellular Location - Mitochondrial; Allosteric Modifier - Acetyl-CoA; Enzyme That Catalyzes a Covalent Modification - PKA

Answer

Required Cofactor - Thiamin; Intracellular Location - Cytoplasmic; Allosteric Modifier - Acetyl-CoA; Enzyme That Catalyzes a Covalent Modification - AMP-activated protein kinase

Question 10

Farber's disease is caused by a deficiency in which enzyme?

Accepted Answer

Ceramidase

Answer

Alpha-galactosidase

Answer

Debranching enzyme

Answer

None of the above

Lipid Metabolism — MCQs

Lipid Metabolism — MCQs

On this page

Practice by Chapter

Want unlimited practice?